Company Search:
Advanced Search
Sponsored Links
Anhui Fengyuan Pharmaceutical Company Snapshot
Anhui Fengyuan Pharmaceutical operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Fengyuan Pharmaceutical with three other companies in this sector in CHINA : Haisco Pharmaceutical Group Co Ltd (2020 sales of 3.33 billion Chinese Renmimbi [US$515.99 million] of which 100% was Pharmaceutical Industry), Heilongjiang ZBD Pharmaceutical Co Ltd (3.33 billion Chinese Renmimbi [US$516.41 million] of which 66% was Pharmaceutical Industry), and Chengdu Kanghong Pharmaceutical Group Co Ltd (3.30 billion Chinese Renmimbi [US$510.65 million] of which 100% was Pharmaceutical Manufacturing).

Sales Analysis. During the first quarter of 2021, sales at Anhui Fengyuan Pharmaceutical totalled 856.71 million Chinese Renmimbi. This is an increase of 16.2% from the 737.12 million Chinese Renmimbi in sales at the company during the first quarter of 2020. During the year ended December of 2020, sales at Anhui Fengyuan Pharmaceutical were 3.32 billion Chinese Renmimbi (US$514.68 million). This is an increase of 2.6% versus 2019, when the company's sales were 3.24 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Anhui Fengyuan Pharmaceutical (and since 2015, sales have increased a total of 114%). Sales of Medicine Retail Circulation saw an increase that was more than double the company's growth rate: sales were up 10.4% in 2020, from 1.53 billion Chinese Renmimbi to 1.69 billion Chinese Renmimbi. Not all segments of Anhui Fengyuan Pharmaceutical experienced an increase in sales in 2020: sales of Other Operations fell 7.3% to 58.33 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Anhui Fengyuan Pharmaceutical also experienced decreases in sales in Medicine Manufacturing (down 4.4% to 1.57 billion Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Anhui Fengyuan Pharmaceutical
  Stock Performance Chart for Anhui Fengyuan Pharmaceutical
  Stock Data: Recent Stock Performance:
  Current Price (6/18/2021): 8.27
(Figures in Chinese Renmimbi)
1 Week -5.9%   13 Weeks 8.2%  
4 Weeks 16.0%   52 Weeks 7.3%  
Anhui Fengyuan Pharmaceutical Key Data:
  Ticker: 000153 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 3,321,182,365
(Year Ending Jan 2021).
Employees: 4,556
  Currency: Chinese Renmimbi Market Cap: 2,581,407,972
  Fiscal Yr Ends: December Shares Outstanding: 312,141,230
  Share Type: A Gu Closely Held Shares: 108,530,909
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.